Search

Author/Creator Bellanger, M.

3. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis. (22nd March 2016)

Authors:
Trasande, L.; Zoeller, R. T.; Hass, U.; Kortenkamp, A.; Grandjean, P.; Myers, J. P.; DiGangi, J.; Hunt, P. M.; Rudel, R.; Sathyanarayana, S.; Bellanger, M.; Hauser, R.; Legler, J.; Skakkebaek, N. E.; Heindel, J. J.
Other Names:
Andersson Anna‐Maria guestEditor.; Bay Katrine guestEditor.; Frederiksen Hanne guestEditor.; Grigor Ken guestEditor.; Skakkebaek Niels E. guestEditor.
Journal:
Andrology
Issue:
Volume 4:Number 4(2016:Jul.)
Page Start:
565
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial – PROFIT. (August 2022)

Authors:
Zhou, K.; Renouf, M.; Perrocheau, G.; Magné, N.; Latorzeff, I.; Pommier, P.; Créhange, G.; Paumier, A.; Bera, G.; Martin, J.; Catton, C.; Bellanger, M.; Supiot, S.
Journal:
Radiotherapy and oncology
Issue:
Volume 173(2022)
Page Start:
306
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. MO-0058 Cost-effectiveness of hypofractionated radiotherapy in intermediate-risk prostate cancer. (May 2022)

Authors:
Renouf, M.; Zhou, K.; Perrocheau, G.; Magné, N.; De Brisson de la Roche, G.; Latorzeff, I.; Pommier, P.; Créhange, G.; Paumier, A.; Bera, G.; Catton, C.; Bellanger, M.; Supiot, S.
Journal:
Radiotherapy and oncology
Issue:
Volume 170(2022)Supplement 1
Page Start:
S31
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗